BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 26992838)

  • 1. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision).
    Marmor MF; Kellner U; Lai TY; Melles RB; Mieler WF;
    Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
    Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
    Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
    Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF; Melles RB
    Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity.
    Melles RB; Marmor MF
    Ophthalmology; 2015 Jan; 122(1):110-6. PubMed ID: 25182842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF; Hu J
    JAMA Ophthalmol; 2014 Sep; 132(9):1105-12. PubMed ID: 24922444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
    Rüther K; Foerster J; Berndt S; Schroeter J
    Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M; Stover NB; Francis PJ; Weleber RG
    Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
    Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
    Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
    Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current screening practice in patients under long-term hydroxychloroquine medication in Taiwan: A nationwide population-based cohort study.
    Yen CY; Lee PH; Yen JC; Chen CC; Hu HY; Tseng PC
    Medicine (Baltimore); 2019 Apr; 98(14):e15122. PubMed ID: 30946384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M; Chan EW; Omar A
    Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
    Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
    Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pericentral hydroxychloroquine retinopathy in Korean patients.
    Lee DH; Melles RB; Joe SG; Lee JY; Kim JG; Lee CK; Yoo B; Koo BS; Kim JT; Marmor MF; Yoon YH
    Ophthalmology; 2015 Jun; 122(6):1252-6. PubMed ID: 25712474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variability of chloroquine and hydroxychloroquine retinopathy among various ethnicities].
    Giocanti-Aurégan A; Couturier A; Girmens JF; Le Mer Y; Massamba N; Barreau E; Audo I;
    J Fr Ophtalmol; 2018 Apr; 41(4):363-367. PubMed ID: 29678344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible early sign of hydroxychloroquine macular toxicity.
    Brandao LM; Palmowski-Wolfe AM
    Doc Ophthalmol; 2016 Feb; 132(1):75-81. PubMed ID: 26792426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal imaging in a severe case of hydroxychloroquine toxicity.
    Bhavsar KV; Mukkamala LK; Freund KB
    Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):377-9. PubMed ID: 25856825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.